Nemera’s electronic add-on for ophthalmic droppers, the e-Novelia, has won the award for best drug delivery device at CPhI Worldwide.
The device aims to help patients benefit from enhanced instructions, immediate usage feedback and client information, and optimised adherence to treatments. Healthcare professionals can also tailor treatments with the device and could help researchers with more efficient clinical studies.
It has also been designed and developed to add new functions that are not provided by standard mechanical devices.
Nemera says e-Novelia has been designed to improve patients’ interaction with their drug by assisting them with:
· Digitalised and interactive Instructions for use through mobile application and on - device screen
· Reminders to take their dose
· Reminders to reload the device with a new drug bottle
· Information about their drug: expiry date, dosage, batch number
· Feedback and guidance to use their device the right way: tilt and shaking indication, buzzer, detection of wrong usage
· Improved ergonomy and user friendliness featuring an eye cup and a bottle squeezing aid
Denise Johnton, Nemera’s VP for global sales said: “We are absolutely thrilled to receive this prestigious award. The Novelia PFMD platform is already a huge success in the market, improving patients' daily lives by giving them an option on Preservative - Free formulations in a multi - dose eye dropper bottle, reducing allergic react ions and itchiness due to preservatives. Our innovation teams are blazing a trail on developing electronic devices to further enhance the patient experience with Novelia and these features can even be used universally for many of our other devices. It is wonderful to see this work recognized as being cutting edge and hugely motivating for our teams. Like our motto says ‘We put patients first’”